FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079379157> ?p ?o ?g. }

• W2079379157 endingPage "1866" @default.
• W2079379157 startingPage "1856" @default.
• W2079379157 abstract "The advent of tumor necrosis factor (TNF)-blocking drugs has provided rheumatologists with an effective, but highly expensive, treatment for the management of established rheumatoid arthritis (RA). Our aim was to explore preclinically the application of camelid anti-TNF VHH proteins, which are single-domain antigen binding (VHH) proteins homologous to human immunoglobulin V(H) domains, as TNF antagonists in a mouse model of RA.Llamas were immunized with human and mouse TNF, and antagonistic anti-TNF VHH proteins were isolated and cloned for bacterial production. The resulting anti-TNF VHH proteins were recombinantly linked to yield bivalent mouse and human TNF-specific molecules. To increase the serum half-life and targeting properties, an anti-serum albumin anti-TNF VHH domain was incorporated into the bivalent molecules. The TNF-neutralizing potential was analyzed in vitro. Mouse TNF-specific molecules were tested in a therapeutic protocol in murine collagen-induced arthritis (CIA). Disease progression was evaluated by clinical scoring and histologic evaluation. Targeting properties were evaluated by 99mTc labeling and gamma camera imaging.The bivalent molecules were up to 500 times more potent than the monovalent molecules. The antagonistic potency of the anti-human TNF VHH proteins exceeded even that of the anti-TNF antibodies infliximab and adalimumab that are used clinically in RA. Incorporation of binding affinity for albumin into the anti-TNF VHH protein significantly prolonged its serum half-life and promoted its targeting to inflamed joints in the murine CIA model of RA. This might explain the excellent therapeutic efficacy observed in vivo.These data suggest that because of the flexibility of their format, camelid anti-TNF VHH proteins can be converted into potent therapeutic agents that can be produced and purified cost-effectively." @default.
• W2079379157 created "2016-06-24" @default.
• W2079379157 creator A5015662504 @default.
• W2079379157 creator A5021997870 @default.
• W2079379157 creator A5039892511 @default.
• W2079379157 creator A5041340664 @default.
• W2079379157 creator A5043369161 @default.
• W2079379157 creator A5048520859 @default.
• W2079379157 creator A5050390108 @default.
• W2079379157 creator A5055677976 @default.
• W2079379157 creator A5057399836 @default.
• W2079379157 creator A5062770314 @default.
• W2079379157 creator A5067342192 @default.
• W2079379157 creator A5075971625 @default.
• W2079379157 creator A5086777523 @default.
• W2079379157 creator A5089769631 @default.
• W2079379157 creator A5090983819 @default.
• W2079379157 date "2006-01-01" @default.
• W2079379157 modified "2023-10-17" @default.
• W2079379157 title "Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis" @default.
• W2079379157 cites W1523595999 @default.
• W2079379157 cites W1605132184 @default.
• W2079379157 cites W1909853035 @default.
• W2079379157 cites W1963522035 @default.
• W2079379157 cites W1964465558 @default.
• W2079379157 cites W1975545950 @default.
• W2079379157 cites W1978576762 @default.
• W2079379157 cites W1980990177 @default.
• W2079379157 cites W1987919062 @default.
• W2079379157 cites W1993791286 @default.
• W2079379157 cites W2006831045 @default.
• W2079379157 cites W2009834607 @default.
• W2079379157 cites W2013843528 @default.
• W2079379157 cites W2014041882 @default.
• W2079379157 cites W2020368956 @default.
• W2079379157 cites W2031092466 @default.
• W2079379157 cites W2034516179 @default.
• W2079379157 cites W2049333722 @default.
• W2079379157 cites W2053536718 @default.
• W2079379157 cites W2054592480 @default.
• W2079379157 cites W2057278101 @default.
• W2079379157 cites W2064976031 @default.
• W2079379157 cites W2070469252 @default.
• W2079379157 cites W2073940609 @default.
• W2079379157 cites W2095553811 @default.
• W2079379157 cites W2096342744 @default.
• W2079379157 cites W2101327971 @default.
• W2079379157 cites W2121915271 @default.
• W2079379157 cites W2125946338 @default.
• W2079379157 cites W2127401827 @default.
• W2079379157 cites W2133039447 @default.
• W2079379157 cites W2155951093 @default.
• W2079379157 cites W2162392434 @default.
• W2079379157 cites W2168848424 @default.
• W2079379157 cites W2460489380 @default.
• W2079379157 cites W72186756 @default.
• W2079379157 doi "https://doi.org/10.1002/art.21827" @default.
• W2079379157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16736523" @default.
• W2079379157 hasPublicationYear "2006" @default.
• W2079379157 type Work @default.
• W2079379157 sameAs 2079379157 @default.
• W2079379157 citedByCount "248" @default.
• W2079379157 countsByYear W20793791572012 @default.
• W2079379157 countsByYear W20793791572013 @default.
• W2079379157 countsByYear W20793791572014 @default.
• W2079379157 countsByYear W20793791572015 @default.
• W2079379157 countsByYear W20793791572016 @default.
• W2079379157 countsByYear W20793791572017 @default.
• W2079379157 countsByYear W20793791572018 @default.
• W2079379157 countsByYear W20793791572019 @default.
• W2079379157 countsByYear W20793791572020 @default.
• W2079379157 countsByYear W20793791572021 @default.
• W2079379157 countsByYear W20793791572022 @default.
• W2079379157 countsByYear W20793791572023 @default.
• W2079379157 crossrefType "journal-article" @default.
• W2079379157 hasAuthorship W2079379157A5015662504 @default.
• W2079379157 hasAuthorship W2079379157A5021997870 @default.
• W2079379157 hasAuthorship W2079379157A5039892511 @default.
• W2079379157 hasAuthorship W2079379157A5041340664 @default.
• W2079379157 hasAuthorship W2079379157A5043369161 @default.
• W2079379157 hasAuthorship W2079379157A5048520859 @default.
• W2079379157 hasAuthorship W2079379157A5050390108 @default.
• W2079379157 hasAuthorship W2079379157A5055677976 @default.
• W2079379157 hasAuthorship W2079379157A5057399836 @default.
• W2079379157 hasAuthorship W2079379157A5062770314 @default.
• W2079379157 hasAuthorship W2079379157A5067342192 @default.
• W2079379157 hasAuthorship W2079379157A5075971625 @default.
• W2079379157 hasAuthorship W2079379157A5086777523 @default.
• W2079379157 hasAuthorship W2079379157A5089769631 @default.
• W2079379157 hasAuthorship W2079379157A5090983819 @default.
• W2079379157 hasConcept C150903083 @default.
• W2079379157 hasConcept C153911025 @default.
• W2079379157 hasConcept C159654299 @default.
• W2079379157 hasConcept C17991360 @default.
• W2079379157 hasConcept C185592680 @default.
• W2079379157 hasConcept C202751555 @default.
• W2079379157 hasConcept C203014093 @default.
• W2079379157 hasConcept C207001950 @default.

• next